# A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.

> **NCT06854939** · — · NOT_YET_RECRUITING · sponsor: **National Cancer Center, Japan** · enrollment: 350 (estimated)

## Conditions studied

- NSCLC, Stage I, II, III

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06854939
- **Lead sponsor:** National Cancer Center, Japan
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06854939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06854939, "A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT06854939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*